Investor's Business Daily on MSN13m
Investing Action Plan: A Big Week For Biotechs, Pharma And Econ, Plus Amazon And Alphabet
The week's investing action plan includes a strong dose of pharma and biotech earnings, January econ reports, plus Amazon and ...
FiercePharma7h
Merck vaccine, Daiichi ADC win approval recommendations in busy week at EU's drug regulator
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
Hosted on MSN7h
4 Healthcare Stocks Poised to Crush Q4 Earnings Estimates
The fourth-quarter 2024 earnings cycle is here, with quite a few healthcare companies having reported results. Early reports ...
Curious about Amgen (AMGN) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Amgen (AMGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the ...
Open Source: Did the Trump 2017 tax cuts help Amgen build its new NC factory?
The Tax Cuts and Jobs Act of 2017 reconfigured the tax code. Did it also enable a pharmaceutical giant to invest in Wake ...
PMLiVE9h
Amgen’s Blincyto granted EC approval for new acute lymphoblastic leukaemia indication
Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic ...
Is Amgen Inc. (AMGN) a Cheap Quarterly Dividend Stock to Invest In?
We recently compiled a list of the 7 Cheap Quarterly Dividend Stocks to Invest in. In this article, we are going to take a ...
Amgen (NASDAQ:AMGN) Price Target Lowered to $295.00 at Citigroup
Amgen (NASDAQ:AMGN – Free Report) had its price target decreased by Citigroup from $310.00 to $295.00 in a research report released on Tuesday morning,Benzinga reports. Citigroup currently has a ...